Cargando…
Perspectives on glucocorticoid treatment for COVID-19: a systematic review
Coronavirus disease 2019 (COVID-19) is a viral pneumonia that can lead to acute respiratory distress syndrome (ARDS). Until the commercialization of a vaccine, pharmacological treatment still represents an important strategy to fight against the ongoing pandemic. Glucocorticoids (GC) were widely use...
Autores principales: | Cordeiro, Leonardo P., Linhares, Eduarda O. N. N., Nogueira, Fernanda G. O., Moreira-Silva, Daniel, Medeiros-Lima, Daniel J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933916/ https://www.ncbi.nlm.nih.gov/pubmed/33666864 http://dx.doi.org/10.1007/s43440-021-00225-3 |
Ejemplares similares
-
Use of glucocorticoids and azithromycin in the therapy of COVID-19
por: de Lemos Neto, Miguel, et al.
Publicado: (2021) -
Dichotomous analysis of gaseous emissions as influenced by the impacts of COVID-19 in Brazil: São Paulo and Legal Amazon
por: Sthel, Marcelo S., et al.
Publicado: (2021) -
Further discussion on glucocorticoid treatment of COVID-19
por: Feng, Yun’ai, et al.
Publicado: (2022) -
Glucocorticoids and COVID-19
por: Bruscoli, Stefano, et al.
Publicado: (2022) -
Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
por: Venter, Gabriella, et al.
Publicado: (2021)